Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
View Patent ↗The invention relates to benzofuran or benzothiophene derivatives, to processes for preparing them, to pharmaceutical compositions comprising them, and to the method of use thereof in the treatment of pathological syndromes of the cardiovascular system.
1. Benzofuran derivatives of general formula:
and their pharmaceutically acceptable salts, in which formula:
A represents a linear or branched C 1 -C 5 alkylene group optionally substituted by a hydroxyl group or A represents a group of general formula:
—R 19 —O—R 20 — (h)
in which R 19 and R 20 , which are identical or different, each represent a linear or branched C 1 -C 4 alkylene group,
R 30 and R 31 , taken together, represent a carbonyl group with the carbon to which they are attached or represent a group of general formula:
—O—R 29 —O— (m)
in which R 29 represents a C 1 -C 4 alkylene group,
T represents hydrogen or a C 1 -C 4 alkyl radical,
R represents:
the cyano, hydroxymethyl, formyl or tetrazolyl group, or
an ester group of general formula:
in which R 4 represents a linear or branched C 1 -C 6 alkyl group or a C 3 -C 6 cycloalkyl group,
R 1 represents hydrogen, a linear or branched C 1 -C 6 alkyl group, a C 3 -C 6 cycloalkyl group, a benzyl group or a phenyl group optionally substituted by one or more substituents selected from halogen atoms, C 1 -C 4 alkyl groups or C 1 -C 4 alkoxy groups or R 1 represents a group of general formula:
in which R 21 represents a linear or branched C 1 -C 4 alkylene group and R 22 represents a linear or branched C 1 -C 4 alkyl group or R 1 represents a group of general formula:
—R 23 —OH (j)
in which R 23 represents a linear or branched C 1 -C 6 alkylene group,
R 2 and R 3 , which are identical or different, represent hydrogen, a linear or branched C 1 -C 6 alkyl group optionally substituted by one or more halogen atoms or by a pyrrolidinyl group, a C 3 -C 6 cycloalkyl group or a group of general formula:
—R 24 —O—R 25 (k)
in which R 24 represents a linear or branched C 1 -C 4 alkylene group and R 25 represents a linear or branched C 1 -C 4 alkyl group,
or R 2 and R 3 , when they are taken together, represent a linear or branched C 3 -C 10 alkylene group
W, W′ and Z are such that:
when W and W′, which are identical, represent CH, Z represents —O— or —S—,
when W represents CH and W′ represents C—R 13 , Z represents
R 13 and
R 14 being identical or different and representing hydrogen, a halogen atom, a C 1 -C 4 alkyl radical or a C 1 -C 4 alkoxy radical,
X represents —O—,
these benzofuran derivatives being in the form of individual isomers or of mixtures of the latter.
2. Benzofuran derivatives according to claim 1 wherein A represents a linear or branched C 1 -C 5 alkylene group.
3. Benzofuran derivatives according to claim 1 wherein R 1 represents hydrogen, a linear or branched C 1 -C 6 alkyl group, a C 3 -C 6 cycloalkyl group, a benzyl group or a phenyl group optionally substituted by one or more substituents selected from halogen atoms, C 1 -C 4 alkyl groups or C 1 -C 4 alkoxy groups.
4. Benzofuran derivatives according to claim 1 of general formula:
and their pharmaceutically acceptable salts, in which:
A represents a linear or branched C 1 -C 5 alkylene group,
T represents hydrogen or a C 1 -C 4 alkyl radical,
R represents:
the cyano, hydroxymethyl, formyl or tetrazolyl group, or
an ester group of general formula:ps
in which R 4 represents a C 1 -C 6 alkyl or C 3 -C 6 cycloalkyl group,
R 1 represents hydrogen, a linear or branched C 1 -C 6 alkyl group, a C 3 -C 6 cycloalkyl group, a benzyl group or a phenyl group optionally substituted by one or more substituents selected from halogen atoms, C 1 -C 4 alkyl groups or C 1 -C 4 alkoxy groups,
R 2 and R 3 , which are identical or different, represent hydrogen, a linear or branched C 1 -C 6 alkyl group or a C 3 -C 6 cycloalkyl group,
or R 2 and R 3 , when they are taken together, represent a linear or branched C 3 -C 10 alkylene group,
W, W′ and Z are such that:
when W and W′, which are identical, represent CH, Z represents —O— or —S—,
when W represents CH and W′ represents C—R 13 , Z represents
R 13 and R 14
being identical or different and representing hydrogen, a halogen atom, a C 1 -C 4 alkyl radical or a C 1 -C 4 alkoxy radical, X represents —O— these benzofuran derivatives being in the form of individual isomers or of mixtures of the latter.
5. Benzofuran derivatives according to claim 1 wherein R represents the isopropoxycarbonyl group.
6. Benzofuran derivatives according to claim 1 wherein R 1 and/or R 2 and/or R 3 represent the n-butyl group.
7. Benzofuran derivatives according to claim 1 in which:
represents the benzoyl group.
8. Benzofuran derivatives according to claim 1 in which:
represents the benzoyl group substituted in the 4-position by an -A- group.
9. Benzofuran derivatives according to claim 1 wherein R 1 represents the n-butyl group, A represents the propylene group and R 2 and R 3 , which are identical, represent the n-butyl group.
10. Isopropyl 2-butyl-3-[4-[3-(dibutylamino)propyl]benzoyl]-1-benzofuran-5- carboxylate and its pharmaceutically acceptable salts.
11. Isopropyl 2-butyl-6-methyl-3-[4-[3-(dibutylamino)propyl]benzoyl]-1-benzofuran-5-carboxylate and its pharmaceutically acceptable salts.
12. Benzofuran derivatives according to claim 1 in which the pharmaceutically acceptable salt is chosen maleate, fumarate, methanesulphonate, benzoate, ascorbate, pamoate, succinate, hexamate, bismethylenesalicylate, acetate, propionate, tartrate, salicylate, citrate, gluconate, lactate, malate, cinnamate, mandelate, citraconate, aspartate, palmitate, stearate, itaconate, glycolate, p-aminobenzoate, glutamate, benzenesulphonate, p-toluenesulphonate and theophyllineacetate salts and the salts formed from an amino acid.
13. Isopropyl 2-butyl-3-[4-[3-(dibutylamino)propyl]benzoyl]-1-benzofuran-5-carboxylate fumarate.
14. Benzofuran derivatives according to claim 1 in which the pharmaceutically acceptable salt is chosen from the hydrochloride, hydrobromide, sulphate, sulphamate, phosphate and nitrate salts.
15. Isopropyl 2-butyl-3-[4-[3-(dibutylamino)propyl]benzoyl]-1-benzofuran-5-carboxylate sulphate.
16. Benzofuran derivatives according to claim 4 wherein R represents the isopropoxycarbonyl group.
17. Benzofuran derivatives according to claim 4 wherein R 1 and/or R 2 and/or R 3 represent the n-butyl group.
18. Benzofuran derivatives according to claim 4 in which:
represents the benzoyl group.
19. Benzofuran derivatives according to claim 4 in which:
represents the benzoyl group substituted in the 4-position by an -A- group.
20. Benzofuran derivatives according to claim 4 wherein R 1 represents the n-butyl group, A represents the propylene group and R 2 and R 3 , which are identical, represent the n-butyl group.
21. Benzofuran derivatives according to claim 4 in which the pharmaceutically acceptable salt is chosen from maleate, fumarate, methanesulphonate, benzoate, ascorbate, pamoate, succinate, hexamate, bismethylenesalicylate, acetate, propionate, tartrate, salicylate, citrate, gluconate, lactate, malate, cinnamate, mandelate, citraconate, aspartate, palmitate, stearate, itaconate, glycolate, p-aminobenzoate, glutamate, benzenesulphonate, p-toluenesulphonate and theophyllineacetate salts and the salts formed from an amino acid.
22. Benzofuran derivatives according to claim 4 in which the pharmaceutically acceptable salt is chosen from the hydrochloride, hydrobromide, sulphate, sulphamate, phosphate and nitrate salts.
23. Benzofuran derivatives according to claim 13 wherein the salt formed from an amino acid is a lysine or histidine salt.